PIK3CA and colorectal carcinoma: For instance, activation of the PI3K/Akt pathway is linked to poor prognosis in CRC [11, 13, 17] and multiple studies report patients with PIK3CA mutations to have an overall higher rate of recurrence and metastasis, as well as lower survival rates [11–13, 93].